Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Abbott Laboratories (ABT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 89,356,536
  • Shares Outstanding, K 1,737,440
  • Annual Sales, $ 20,853 M
  • Annual Income, $ 1,400 M
  • 36-Month Beta 1.06
  • Price/Sales 4.29
  • Price/Cash Flow 18.44
  • Price/Book 2.81

Price Performance

See More
Period Period Low Period High Performance
1-Month
49.33 +6.45%
on 08/24/17
52.60 -0.17%
on 09/11/17
+2.80 (+5.63%)
since 08/22/17
3-Month
47.83 +9.78%
on 07/13/17
52.60 -0.17%
on 09/11/17
+3.24 (+6.58%)
since 06/22/17
52-Week
37.38 +40.48%
on 12/01/16
52.60 -0.17%
on 09/11/17
+10.29 (+24.37%)
since 09/22/16

Most Recent Stories

More News
Top Stock Reports for Caterpillar, Texas Instruments & Alphabet

Top Stock Reports for Caterpillar, Texas Instruments & Alphabet

GOOGL : 943.26 (-0.45%)
ABT : 52.51 (+2.10%)
CAT : 124.43 (-0.29%)
ANTM : 182.86 (-0.35%)
ADBE : 148.50 (-0.54%)
TXN : 88.27 (+2.58%)
Here's Why You Should Add Abbott (ABT) to Your Portfolio Now

The market is upbeat about Abbott (ABT) acquiring the national reimbursement for FreeStyleLibre glucose monitoring system in the United Kingdom. Several product launches also add value.

CHE : 191.86 (+0.59%)
EW : 110.64 (+0.28%)
ABT : 52.51 (+2.10%)
AMED : 52.11 (+1.48%)
Abbott Secures FDA Approval for MRI-Compatibility for the Company's Ellipse(TM) ICD

Abbott (NYSE: ABT) today announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for one of Abbott's most widely-used implantable cardioverter defibrillators...

ABT : 52.51 (+2.10%)
Global Spinal Cord Stimulation Market: Industry Analysis & Outlook 2017-2021 - Research and Markets

The "Global Spinal Cord Stimulation Market: Industry Analysis & Outlook (2017-2021)" report has been added to Research and Markets' offering.

NVRO : 87.70 (+1.67%)
ABT : 52.51 (+2.10%)
MDT : 79.70 (+0.21%)
Abbott Hosts Conference Call for Third-Quarter Earnings

Abbott (NYSE: ABT) will announce its third-quarter 2017 financial results on Wednesday, Oct. 18, 2017, before the market opens.

ABT : 52.51 (+2.10%)
DiCello Levitt & Casey and Tousley Brain Stephens File Class Action Lawsuit Over Recalled Implantable Cardiac Defibrillators

A nationwide class action lawsuit has been filed by law firms DiCello Levitt & Casey and Tousley Brain Stephens on behalf of third party insurance payors against St. Jude Medical, Inc. and...

ABT : 52.51 (+2.10%)
STJ : 80.82 (+0.16%)
Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc.

Abbott (NYSE: ABT) announced today that it is extending its previously announced tender offer to purchase for cash all outstanding shares of Series B Convertible Perpetual Preferred Stock (the "Preferred...

ABT : 52.51 (+2.10%)
ALR : 50.35 (unch)
Abbott Declares 375th Consecutive Quarterly Dividend

The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 26.5 cents per share.

ABT : 52.51 (+2.10%)
Abbott's (ABT) FreeStyle Libre Gets UK Reimbursement Nod

Abbott's (ABT) diabetes care segment to further strengthen with the FreeStyle Libre glucose monitoring system's latest U.K. national reimbursement grant.

EW : 110.64 (+0.28%)
ABT : 52.51 (+2.10%)
LNTH : 17.35 (-0.57%)
JNJ : 131.39 (-0.27%)
FreeStyle® Libre Flash Glucose Monitoring Technology Gains Reimbursement Approval from the United Kingdom's National Health Service

Abbott (NYSE: ABT) today announced that the FreeStyle® Libre system is now available for reimbursement in the United Kingdom (UK). The National Health Service (NHS) Business Services Authority has approved...

ABT : 52.51 (+2.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy and ranks in the Top 1% of all short term signal directions.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.

See More

Support & Resistance

2nd Resistance Point 53.28
1st Resistance Point 52.89
Last Price 52.51
1st Support Level 51.81
2nd Support Level 51.12

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.